| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.42 | 6e-35 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.39 | 1e-34 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.41 | 2e-34 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.41 | 9e-21 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-13 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-12 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-12 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-11 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-11 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |